Table 1. Distribution of study participants.
Category | Study participants | Number |
Category 1 | Histopathological and clinically confirmed cases of OSMF | 60 |
Category 2 | Histopathological and clinically confirmed cases of OL | 60 |
Category 3 | Histopathological and clinically confirmed cases of OLP | 60 |
Category 4 | Sex and age coincided, healthy controls free of any indications or symptoms of the conditions listed above | 60 |